Patent details

EP1505993 Title: SENSITIZATION OF NEOPLASTIC CELLS TO RADIATION THERAPY WITH ONCOLYTIC VIRUSES

Basic Information

Publication number:
EP1505993
PCT Application Number:
PCT/CA/2003/000695
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP037247137
PCT Publication Number:
WO/2003/094939
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SENSITIZATION OF NEOPLASTIC CELLS TO RADIATION THERAPY WITH ONCOLYTIC VIRUSES
French Title of Invention:
SENSIBILISATION DE CELLULES NEOPLASIQUES A UNE RADIOTHERAPIE AU MOYEN DE VIRUS ONCOLYTIQUES
German Title of Invention:
ONKOLYTISCHE VIREN ZUR SENSIBILISIERUNG NEOPLASTISCHER ZELLEN FÜR DIE STRAHLENTHERAPIE
SPC Number:

Dates

Filing date:
08/05/2003
Grant date:
25/04/2012
EP Publication Date:
25/04/2012
PCT Publication Date:
20/11/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/02/2005
EP B1 Publication Date:
25/04/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
08/05/2012
Expiration date:
08/05/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/05/2003
 
 

Name:
Oncolytics Biotech Inc.
Address:
Suite 210 1167 Kensington Crescent N. W., Calgary, AB T2N 1X7, Canada (CA)

Inventor

1

Name:
COFFEY Matthew, C.
Address:
Canada (CA)

2

Name:
MORRIS Donald
Address:
Canada (CA)

3

Name:
BALL Douglas
Address:
Canada (CA)

4

Name:
THOMPSON Bradley, G.
Address:
Canada (CA)

Priority

1

Priority Number:
378948 P
Priority Date:
10/05/2002
Priority Country:
United States (US)

2

Priority Number:
443189 P
Priority Date:
29/01/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 35/76;
Filing date Document type Number of pages